Ana I. Velázquez Mañana, MD, MSc, FASCO
@anavmanana
Thoracic Onc @UCSFCancer @ZSFGCare | Boricua🇵🇷 Clinical Trial Disparities, Health Equity, DEIA @LatinXOncology | 🎓@medupr @uprm @NCSP_UCSF | Views are mine
ID: 979744921056768000
https://coi.asco.org/share/GXF-G67R/Ana%20Velazquez%20Manana 30-03-2018 15:39:26
12,12K Tweet
6,6K Followers
5,5K Following
Clinical Trials 101: How Do I Find a Clinical Trial? - Patient Education Ambassadors 2023-24 youtu.be/goNQASEjrYk?si… via YouTube In this video, Drs. Meera Ragavan, MD MPH and Ivy Ivy Riano, M.D. discuss how to find a clinical trial. #PatientEducation2024 #ClinicalTrials For
Lift up & celebrate your #WomeninOncology colleagues and friends! Submit your nominations for the #LEAD2024 Woman Oncologist of the Year Award & Rising Star Award by August 30th 🔗bioascend.com/lead-awards/ Women Leaders in Oncology Hematology & Oncology Women Physicians Group—HOWPG Hem-Onc Fellows Network ASCO TECAG Women In Lymphoma - [email protected]
Honored to be asked to speak at this wonderful conference this year!!! Women in Hematology-Oncology join me there at the Lowe’s in Coronado! You could not ask for a better location! UCSD Hematology/Oncology Fellowship UC San Diego Health Moores Cancer Center Hematology & Oncology Women Physicians Group—HOWPG
With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and MARIPOSA (amivantamab plus lazertinib) all now FDA approved 1L options for #EGFR NSCLC, how do we select the optimal regimen? Drs. Natasha Leighl, Tom Newsom-Davis and I discuss. iaslc.org/iaslc-news/lun…
Save the date! Sunday September 9th at 8 pm PDT and dress to impress Do you have your outfit yet? Stephen V Liu, MD Coral Olazagasti, MD Brendon Stiles Ana I. Velázquez Mañana, MD, MSc, FASCO Young Lung Cancer Initiative Linda Martin
At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought! UC Davis Comprehensive Cancer Cent City of Hope USC Norris Comprehensive Cancer Center
Phase III KEYNOTE 789 results Journal of Clinical Oncology: platinum + pemetrexed + pembrolizumab vs placebo in #EGFR NSCLC post TKI (n=492). Adding pembro did not improve outcomes (PFS 5.6m vs 5.5m, HR 0.80; OS 15.9m vs 14.7m, HR 0.84) and added toxicity. ascopubs.org/doi/10.1200/JC…
Excited to share I have joined the FDA! Thank you FDA Oncology & FDA Jobs for the warm welcome! #LatinasInMedicine #LatinosInOncology ASCO TECAG
Our GRACE Spanish Therapy forum dont miss the presentations cancergrace.org/post/vod-foro-… Ivy Riano, M.D. Dr. Estela Rodriguez Andres F. Cardona Claudio Martin #lungcancer #lcsm
🥳 Happy Birthday today to the amazing Coral Olazagasti, MD my boricua #thoraciconcology #healthequity researcher hermana Sylvester Comprehensive Cancer Center #LatinasInMedicine #FlorezLab
Two days left! Submit your nominations for the #LEAD2024 Woman Oncologist of the Year & Rising Star Awards by 8/30! Join us in beautiful Coronado, CA ! Hem-Onc Fellows Network Women In Lymphoma - [email protected] Women in Oncology Hematology & Oncology Women Physicians Group—HOWPG ASCO TECAG
Excellent and timely piece Cristiane D Bergerot, Mazie Tsang, MD, MAS, MS, and Ramy Sedhom, MD. ✅ 💻Telehealth has been critical to many of my older adult patients and those living in rural parts of the state. Unfortunately, the flexible provisions associated with telehealth given after the pandemic
🔥#WCLC24 🎯Social Media & Communications Workshop 🌟Faculties🌟 ✅Matthew Smeltzer ✅Aakash Desai, MD, MPH ✅Dr. Estela Rodriguez ✅Karen Reckamp, MD, MS ✅Ana I. Velázquez Mañana, MD, MSc, FASCO ✅Dusty Joy Donaldson ✅Charu Aggarwal, MD, MPH, FASCO #LCSM IASLC OncoAlert cattendee.abstractsonline.com/meeting/20598